Explain this page
Arphra AIPlain-English read on Curaleaf Holdings, Inc.’s valuation06-09today
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $13.02 (+31.25%)
Candlestick · 1Y
Open in chart workstation →CURLF
10.43+380.65%H 12.45L 1.86MA50 3.43MA200 —Avg vol 1.0M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.89% | -4.62% | -4.43% | +43.77% | +3.66% | +31.22% | +301.62% | +9.13% | -75.16% | -43.48% | -43.48% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$10.43
Bid
$10.43
1,000 sh
Ask
$10.43
4,900 sh
Spread
$0.000
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- 3 Leading Marijuana Stocks Investors Are Watching in June 2026marijuanastocks.com·Jun 09, 2026
- Curaleaf Confirms Effective Date of Reverse Stock Splitprnewswire.com·Jun 03, 2026
- Curaleaf Confirms Effective Date of Reverse Stock Splitprnewswire.com·Jun 03, 2026
- Curaleaf Bolsters Florida Footprint with Two New Medical Dispensaries in Jacksonville Beach and Fernandina Beachprnewswire.com·May 08, 2026
- Curaleaf Reports First Quarter 2026 Results: Robust Growth and Net Incomeprnewswire.com·May 05, 2026
- Curaleaf Announces Appointment of Torsten Greif to Board of Directorsprnewswire.com·May 01, 2026
- Curaleaf Announces Appointment of Torsten Greif to Board of Directorsprnewswire.com·May 01, 2026
- Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharmaprnewswire.com·Apr 30, 2026
Peers
No peer list available for CURLF.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|